Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SDAI ( (SG:5TI) ) has issued an update.
SDAI Limited is set to launch its Bluecode Biotech B-III skincare series in Singapore and China, marking a significant step in its strategic transformation into a biotechnology company. The launch, featuring products like the Photoprotective Bio Facial Mist and Apple Fruit Cell Serum, aims to position SDAI as a leader in cellular rejuvenation by utilizing cutting-edge bioengineering and plant stem cell technologies. This move is expected to enhance SDAI’s market presence in the high-growth anti-aging sector, with products distributed through major e-commerce platforms to maximize reach.
More about SDAI
SDAI Limited, incorporated in Singapore, is transitioning into a biotechnology company with a focus on anti-aging products. The company is leveraging advanced plant stem cell technology to develop innovative skincare solutions.
Current Market Cap: S$33.97M
See more data about 5TI stock on TipRanks’ Stock Analysis page.